BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Federici S, Goggi G, Quinton R, Giovanelli L, Persani L, Cangiano B, Bonomi M. New and consolidated therapeutic options for pubertal induction in hypogonadism: in-depth review of the literature. Endocr Rev 2021:bnab043. [PMID: 34864951 DOI: 10.1210/endrev/bnab043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Šmigoc Schweiger D, Davidović Povše M, Trebušak Podkrajšek K, Battelino T, Avbelj Stefanija M. GNRHR-related central hypogonadism with spontaneous recovery – case report. Ital J Pediatr 2022;48:184. [DOI: 10.1186/s13052-022-01377-5] [Reference Citation Analysis]
2 Sun T, Xu W, Chen Y, Niu Y, Wang T, Wang S, Xu H, Liu J. Reversal of idiopathic hypogonadotropic hypogonadism in a Chinese male cohort. Andrologia 2022;:e14583. [PMID: 36123965 DOI: 10.1111/and.14583] [Reference Citation Analysis]
3 Giovanelli L, Quinton R, Cangiano B, Colombo S, Persani L, Bonomi M, Chiodini I. FSH and bone: Comparison between males with central versus primary hypogonadism. Front Endocrinol 2022;13:939897. [DOI: 10.3389/fendo.2022.939897] [Reference Citation Analysis]
4 Rastrelli G, Maggi M, Corona G. What are the pharmacological considerations for male congenital hypogonadotropic hypogonadism? Expert Opin Pharmacother 2022;23:1009-13. [PMID: 35674463 DOI: 10.1080/14656566.2022.2084690] [Reference Citation Analysis]